The US Food and Drug Administration (FDA) has cleared for marketing the first devices indicated for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision, according to the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE ...

Please provide your email address to receive an email when new articles are posted on . None of the largest U.S. insurers provide coverage for intragastric balloon or endoscopic sleeve gastroplasty.

Forbes contributors publish independent expert analyses and insights. A study just published in JAMA could unveil a new direction in the landscape of weight loss interventions. Endoscopic sleeve ...

CHICAGO – A new, nonsurgical weight-loss procedure — which involves inserting a tube down a patient's throat and suturing the stomach — is safe and effective, a new study finds. During the procedure, ...

In an analysis of adults with class II obesity (BMI 35-39.9), endoscopic sleeve gastroplasty (ESG) added 0.06 more quality-adjusted life-years while costing $33,583 less than semaglutide (Wegovy) over ...

ESG is a minimally invasive procedure that makes your stomach smaller and limits the amount of food you can eat. It’s a type of bariatric surgery known as a restrictive procedure. Some scientists ...

A study presented at Digestive Disease Week examined the effectiveness of non-surgical endoscopic sleeve gastroplasty in individuals struggling with obesity who are not candidates for weight loss ...